发明名称 composto, composição farmacêutica, uso de um composto, e método para tratar uma doença ou distúrbio.
摘要 The present invention provides novel compounds that inhibit cell proliferation and cell division and that inhibit the activation of Hypoxia Inducible Factor (HIF)-mediated transcription and signaling under hypoxic conditions. In one aspect, the compounds of the present invention are useful for the preparation of a medicament for the treatment or prevention of a disease or disorder selected from the group consisting of an inflammatory disease, a hyperproliferative disease or disorder, a hypoxia-related pathology and a disease characterized by excessive vascularisation. Also provided is a pharmaceutical composition comprising a compound of the invention and a second therapeutic agent or radiation useful for the treatment or prevention of the mentioned diseases or disorders. In a first aspect the present invention relates to a compound having a structure according to formula (I).
申请公布号 BRPI0923856(A2) 申请公布日期 2015.10.20
申请号 BR2009PI23856 申请日期 2009.12.30
申请人 EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) E ELARA PHARMACEUTICALS GMBH 发明人 ARANTXA ENCINAS LOPEZ;BERND JANSSEN;BERND WENDT;CHRISTOPH SCHULTES;JOCHEN AMMENN;JOE LEWIS;JORGE ALONSO;MARCEL MUELBAIER
分类号 A61K31/18;A61K31/341;A61K31/381;A61K31/41;A61P35/00;C07C311/21;C07D207/416;C07D213/76;C07D231/42;C07D249/14;C07D257/04;C07D261/16;C07D277/52;C07D307/66;C07D333/36 主分类号 A61K31/18
代理机构 代理人
主权项
地址